SBSaule Balmagambetova

Saule Balmagambetova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Saule Balmagambetova has a total of 163 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prospective External Validation of the HFA-ICOS Baseline Cardiovascular Risk Classification in Women with Breast Cancer Receiving Anthracycline-Containing Therapy in a Central Asian Cohort

    by Aiganym Amanova, Bekbolat Zholdin, Saule Balmagambetova, Iliada Talipova, Gulnara Kurmanalina, Saule Madinova, Mira Baspayeva, Kulparshan Kubenova, Gulmira Sultanbekova, Maria Poltavskaya, et al.

    Background/Objectives: The HFA-ICOS baseline cardiovascular risk classification was developed to standardize pretreatment risk stratification before potentially cardiotoxic cancer therapy, but its external performance across diverse populations remains incompletely characterized. We prospectively evaluated its performance in women with breast cancer receiving anthracycline-containing therapy in Central Asia. Methods: This prospective single-center external validation study used data from the PREDICATE cohort (ISRCTN12628444). Participants were classified at baseline as being at low, moderate, high, or very high cardiovascular risk according to the HFA-ICOS classification before treatment and outcome ascertainment; the high- and very-high-risk categories were pooled for analysis because of small numbers. Participants underwent serial cardiovascular surveillance, including echocardiographic assessment of left ventricular ejection fraction and global longitudinal strain, together with serial cardiac biomarker measurements. The primary outcome was cancer therapy-related cardiac dysfunction (CTRCD), defined according to the 2022 ESC cardio-oncology criteria. Results: The analysis included 108 participants. CTRCD occurred in 43 of 108 participants (39.8%). The observed proportion of participants who developed CTRCD increased from 30.0% in the low-risk group to 47.5% in the moderate-risk group and 75.0% in the high/very-high-risk group (p = 0.026). Kaplan–Meier analysis demonstrated significant separation of CTRCD-free survival across HFA-ICOS risk categories (log-rank χ2 = 10.12; p = 0.006). Compared with the low-risk group, the hazard of CTRCD was higher in the moderate-risk group (hazard ratio [HR], 2.16; 95% confidence interval [CI], 1.13–4.13) and high/very-high-risk group (HR, 3.59; 95% CI, 1.42–9.11). Discrimination was modest (area under the curve, 0.630; 95% CI, 0.530–0.724). Conclusions: The HFA-ICOS classification demonstrated a clear ordinal gradient in CTRCD risk and significant time-to-event separation but showed limited discrimination at the individual-patient level. It may guide initial risk stratification but should be complemented by longitudinal cardiovascular surveillance rather than used as a stand-alone predictor.

  • Open Access

    The oncogenic role of human papillomavirus in breast cancer: a comprehensive systematic review and meta-analysis

    by Dana Koishybayeva, Saule Balmagambetova, Bazylbek Zhakiev, Arip Koishybayev, Nadiar M. Mussin, Svetlana Sakhanova, Marzhan Aitmagambetova, Anar Tulyayeva, Amin Tamadon

    Introduction: Human papillomavirus (HPV) has been increasingly implicated in the pathogenesis of breast cancer (BC), though its role remains controversial. Understanding HPV prevalence and genotype distribution across histological types and regions may clarify this potential association. Methods: A comprehensive systematic review and meta-analysis was conducted using PubMed, Scopus, and Web of Science databases for studies published between January 1990 and April 2025. Eligible studies reported HPV prevalence in BC tissues stratified by histological classification. Non-English studies, reviews, and those lacking histological stratification were excluded. Data from 49 studies encompassing 4,173 BC cases were extracted. Pooled HPV prevalence and odds ratios (ORs) were calculated using random-effects models. Subgroup analyses were performed by histology, geographic region, and HPV genotype (16/18). Risk of bias was assessed using the Joanna Briggs Institute (JBI) checklist for cross-sectional studies and the Newcastle–Ottawa Scale for case-control designs. Results: The pooled prevalence of HPV in BC tissues was 23% (95% CI: 18–28%), highest in invasive ductal carcinoma (24%). HPV-positive individuals exhibited a 3.6-fold higher risk of developing BC (OR = 3.63, 95% CI: 2.33–5.64), with the strongest association in invasive lobular carcinoma (OR = 4.41). HPV-18 showed a more consistent correlation with BC than HPV-16. Regional variation was observed, with Asian populations showing higher HPV prevalence and stronger associations. Discussion: This meta-analysis suggests a significant association between HPV infection—particularly genotype 18—and breast cancer risk, especially in Asian regions and specific histological subtypes. These findings highlight the need for mechanistic studies and standardized molecular detection to elucidate the potential oncogenic role of HPV in breast tissue. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=1051960 identifier CRD420251051960


  • Open Access

    PROSPECTS FOR DEVELOPING AN INTEGRATIVE CANCER PATIENT REHABILITATION MODEL: A LITERATURE REVIEW

    by G.S. Karabasova, N.A. Abenova, P.Zh. Aitmagambet, A.B. Tulyaeva, S.K. Balmagambetova

    Relevance: Despite significant progress in diagnosing and treating oncological diseases, rehabilitation remains poorly integrated into comprehensive patient care. As the number of cancer survivors increases, the development of personalized and multidisciplinary rehabilitation models becomes especially important to ensure sustainable recovery and improved quality of life. The study aimed to examine scientific studies analyzing modern approaches to cancer patient rehabilitation and to develop an integrative model that ensures a personalized and multidisciplinary approach to recovery. Methods: A literature review was conducted using the Scopus, Web of Science, PubMed, Google Scholar, and ScienceDirect databases for publications from 2015 to 2024. Inclusion criteria: publications in Russian and English considering the physical, psychological, nutritional, social, and telemedicine rehabilitation of cancer patients. Exclusion criteria: case reports and clinical symptoms or complications not related to rehabilitation. A total of 94 publications were selected, of which 42 were included in the analysis. Results: The State Strategy of Kazakhstan for 2023-2027 declares the introduction of an integrated approach to oncological rehabilitation; however, problems of standardization, staff shortages, and accessibility of services remain. The approaches of Germany, the United States, and Japan are described, and various models are illustrated. Six key components of the integrative model are identified: physical activity, psychological support, nursing support, pelvic and sexual rehabilitation, telemedicine, and nutritional support. Conclusion: Integrating multidisciplinary cancer rehabilitation into the healthcare system is essential for improving quality of life, reducing disability, and enhancing the social adaptation of cancer patients. Adapting international practices to the national context will help improve the effectiveness of rehabilitation programs in Kazakhstan

  • Open Access

    PROSPECTS FOR DEVELOPING AN INTEGRATIVE CANCER PATIENT REHABILITATION MODEL: A LITERATURE REVIEW

    by Г.с. Карабасова, Н.а. Абенова, P. Aitmagambet, A. Tulyaeva, С.к. Балмагамбетова, П.ж. Айтмағанбет

    Relevance: Despite significant progress in diagnosing and treating oncological diseases, rehabilitation remains poorly integrated into comprehensive patient care. As the number of cancer survivors increases, the development of personalized and multidisciplinary rehabilitation models becomes especially important to ensure sustainable recovery and improved quality of life. The study aimed to examine scientific studies analyzing modern approaches to cancer patient rehabilitation and to develop an integrative model that ensures a personalized and multidisciplinary approach to recovery. Methods: A literature review was conducted using the Scopus, Web of Science, PubMed, Google Scholar, and ScienceDirect databases for publications from 2015 to 2024. Inclusion criteria: publications in Russian and English considering the physical, psychological, nutritional, social, and telemedicine rehabilitation of cancer patients. Exclusion criteria: case reports and clinical symptoms or complications not related to rehabilitation. A total of 94 publications were selected, of which 42 were included in the analysis. Results: The State Strategy of Kazakhstan for 2023-2027 declares the introduction of an integrated approach to oncological rehabilitation; however, problems of standardization, staff shortages, and accessibility of services remain. The approaches of Germany, the United States, and Japan are described, and various models are illustrated. Six key components of the integrative model are identified: physical activity, psychological support, nursing support, pelvic and sexual rehabilitation, telemedicine, and nutritional support. Conclusion: Integrating multidisciplinary cancer rehabilitation into the healthcare system is essential for improving quality of life, reducing disability, and enhancing the social adaptation of cancer patients. Adapting international practices to the national context will help improve the effectiveness of rehabilitation programs in Kazakhstan

  • Open Access

    Chemotherapy-Induced Endothelial Dysfunction: a Bibliometric Analysis of Research Trends from 1994 to 2024

    by Aiganym Amanova, Saule K. Balmagambetova, Zhenisgul Tlegenova, Kulparshan Kubenova, Gulnara Kurmanalina, Bekbolat Zholdin

    Chemotherapy-induced endothelial damage is a complex issue characterized by cardiovascular toxicity and cellular injury. This study aims to analyze primary research areas related to chemotherapy-induced endothelial dysfunction, focusing on countries, institutions, journals, authors, and keywords. Methods. The research employs a descriptive bibliometric design to collect and analyze data from 3,430 publications indexed in the Web of Science and Scopus databases, spanning the years 1994-2024. The bibliometric analysis includes English-language research articles and review papers examining endothelial dysfunction in chemotherapy patients. Data analysis was conducted using RStudio and the Bibliometrix R package, with VOSviewer utilized for visualization. Results. The annual publication trend reveals fluctuations, peaking in 2005 while showing sustained interest in recent years. The United States leads in publication volume with 1,328 articles, closely followed by China and Japan. High levels of international collaboration were noted, particularly between the United States and European countries. Key contributing institutions include Harvard Medical School in the USA and the National Cancer Institute, while prominent authors such as Wang and Kim make significant contributions to the field. "Cancer Research" is recognized as one of the most influential journals, highlighting the interdisciplinary relevance of this field. Conclusions. This bibliometric analysis highlights the evolving key research trends related to angiogenesis, VEGF inhibitors, and the need to increase international cooperation. Given the recent introduction of new classes and groups of chemotherapeutic drugs into practice and the growing body of knowledge in this area, a renewed surge of interest in this topic can be anticipated.

  • Mesenchymal stem cell therapy for diabetes: An umbrella review

    by Dana Koishybayeva, Adilet Amirashov, Saule Balmagambetova, Nadiar M. Mussin, Amin Tamadon


  • Selected Psychological Features of Personality and the Level of Internality in Patients of a Multidisciplinary Hospital

    by Victoria Kononets, Alua Miraleyeva, Saule Balmagambetova, Gulmira Zharmakhanova, Gulnara Batyrova, Ilya Derkach, Nadiar Mussin

    The levels of extraversion-introversion, neuroticism, psychoticism, and locus of control are of particular interest when researching samples of people with various health disorders. The study aims to describe the psychological profile according to Eysenck’s personality type and internality characteristics in patients of a multidisciplinary hospital’s trauma, neurological, and cardiological departments. The combined survey/case-control study with 58 in-patient participants and 58 controls was performed from July to December 2023 in a multidisciplinary clinic in Aktobe. The Rotter Locus of Control Questionnaire and the Hans and Sibylle Eysenck Personality Type Questionnaire were used to collect data. The levels of extraversion, neuroticism, and psychoticism were significantly higher in neurological patients (17.0 (15.0;18.0), 18.0 (14.0;21.0), and 11.0 (9.0;13.0), respectively). Cardiac patients showed the highest indicators of social desirability, 17.0 (16.0; 18.0), and the internality of achievements, 7.0 (5.5; 8.0). There were no significant differences between the groups in general internality and internality toward failure and health. Weak positive correlations with age were found on the scales of lying and internality in the field of achievements, failures, and family relationships, as well as a negative correlation between age and internality concerning health and illness (0.27; 0.28; 0.24; 0.38; -0.22, respectively). Analyzing the psychological profile of cardiac patients in our study confirmed the researchers’ version of type D behavior (a combination of negative emotionality, restraint, lack of self-confidence, and uncertainty) in this group. Compared with the controls, in-patient participants recorded relatively low levels of internality in business relations and, vice versa, high internality in family relations, particularly in men. Thus, stress caused by illness, especially long-term chronic pathology, affects the patient’s psychological profile and initiates a reassessment of values.

  • Open Access

    Next-generation sequencing and bioinformatics analysis in breast cancer research: Insights from Western Kazakhstan

    by Marzhan Aitmagambetova, Nazar Seidalin, Dmitriy Babenko, Gaziza Smagulova, Saule Balmagambetova, Arip Koishybaev, Anar Tulyayeva, Nurgul Kereyeva, Dinara Zholmukhamedova, Azamat Zharylgapov, et al.

    Breast cancer (BC) is one of the most prevalent malignancies among women worldwide and a leading cause of cancer-related mortality. Studying gene mutations associated with BC risk in Kazakh women can help identify hereditary predispositions and facilitate early prevention. Next-generation sequencing (NGS) technology was used to sequence 113 candidate genes, followed by bioinformatics analysis, on BC patients from Western Kazakhstan. NGS sequencing revealed 28 polymorphisms from the genome-wide association studies catalog, seven of which were identified as statistically significant risk polymorphisms for BC: RARG (Rs2229774), FGFR2 (Rs2981582), ATM (Rs1800057), MAP3K1 (Rs889312), BRCA2 (Rs11571833), FGFR2 (Rs7895676), and FGFR2 (Rs1219648). Inheritance model analysis showed that the polymorphism in the Rs2981582 of the FGFR2 gene increased the likelihood of developing BC across four inheritance models. The Rs2229774 polymorphism of the RARG gene elevated BC risk in three models, whereas the Rs889312 polymorphism of the MAP3K1 gene did so in two models. The Rs137852985 polymorphism of the BRIP1 gene raised BC risk in four models, and Rs137852576 of the AR gene increased the risk in the codominant model. In a one-factor risk prediction, 32 significant factors were identified, with risks ranging from 69.7% to 90.6%. The combination of polymorphisms “Rs2229774 (AG),” “Rs889312 (AA, CC),” and “Age <54 years” yielded a high-risk assessment (95.8%), with a predictive quality score of 0.88. Overall, NGS sequencing identified six statistically significant gene polymorphisms (ATM Rs1800057, RARG Rs2229774, BRCA2 Rs11571833, MAP3K1 Rs889312, FGFR2 Rs2981582, and BRIP1 Rs137852985) associated with a high risk of BC in Kazakh women.

  • Risk Factors Associated with Long COVID-19: A Narrative Review

    by Saulesh S. Kurmangaliyeva, Saltanat T. Urazayeva, Yerlan Sh. Bazargaliyev, Khatimya I. Kudabayeva, Kairat B. Kurmangaliyev, Saule K. Balmagambetova, Akzhan M. Madenbayeva

    Studying the consequences of coronavirus infections caused by the SARS-CoV- 2 virus has become crucial in light of its widespread occurrence in society, and the frequent observation of persistent symptoms and health impairments following recovery from the acute phase of the illness. The pandemic has brought about a new chronic, debilitating condition known as long COVID, which deserves serious attention from scientific and medical communities. Currently, we have conflicting knowledge about the factors that may increase the risk of developing such a debilitating condition. The aim of this review was to assess prognostic risk factors for the development of post-COVID-19 conditions. We conducted a systematic search in the databases PubMed, Web of Science, Scopus, CyberLeninka, and the eLibrary electronic library for reports on post-COVID-19 conditions up to April 2024. A total of 52 full-text studies meeting the inclusion criteria were analyzed from both Russian and international sources. The resulting review paper presents a comprehensive overview of recent studies aimed at examining factors preceding COVID-19 infection (gender, age, comorbidities, and others), factors related to COVID-19 infection (severity of acute phase, influence of biomarkers), and the impact of vaccinations on longterm consequences. Much remains unclear regarding long COVID and its risk factors due to conflicting data, possibly caused by the variety of symptoms and complex pathophysiology, including long-term organ damage and unresolved inflammatory processes. This review underscores the high prevalence of post-COVID conditions and the ambiguity in identifying risk factors, necessitating further research for effective management of these conditions.


  • Open Access

    Attitude toward vaccination against COVID-19 and acceptance of the national “QazVac” vaccine in the Aktobe city population, West Kazakhstan: A cross-sectional survey

    by Saltanat T. Urazayeva, Saulesh S. Kurmangaliyeva, Asset A. Kaliyev, Kymbat Sh. Tussupkaliyeva, Arman Issimov, Aisha B. Urazayeva, Zhuldyz K. Tashimova, Nadiar M. Mussin, Toleukhan Begalin, Aimeken A. Amanshiyeva, et al.

    The scale of emergency caused by COVID-19, the ease of survey, and the crowdsourcing deployment guaranteed by the latest technology have allowed unprecedented access to data describing behavioral changes induced by the pandemic. The study aimed to present the survey results identifying attitudes toward vaccination against COVID-19 among the population of West Kazakhstan, the level of confidence in the national QazVac vaccine, and the role of different sources of information on COVID-19 in decision-making concerning vaccination. A computer-assisted survey was conducted using WhatsApp messenger. Overall, 2,009 participants responded, with a response rate of 92%. Most (83.1%) were immunized against COVID-19; among them, 20.1% obeyed the request of their employers that had been practiced within non-pharmaceutical interventions to contain the disease. The youngest respondents, individuals with a college education, students, and employed people, as well as those with chronic diseases, showed positive attitudes toward vaccination (all p<0.05). About two-thirds of respondents (69.2%) expressed trust in all types of vaccines against COVID-19. Of those who refused vaccination (16.9%), about one-third feared vaccination consequences, and more than a third (38.2%) reported anti-vaccine sentiments. The decisive factors in accepting vaccination were trust in official sources of information (reports of medical experts, etc.) and, mainly, subjectively interpreted sufficiency of information about the disease, which had increased the odds of being vaccinated by 63.9% (OR 1.71, 95% CI [1.3;2.26], p<0.05). Confidence in the domestic QazVac vaccine was expressed by 37.7% of respondents. History and severity of COVID-19 disease did not play a role in positive perceptions of vaccination, while illness after vaccination substantially affected vaccination approval (p 0.021). No significant differences have been observed regarding the overall performance across five vaccines (QazVac, Sputnik V, CoronaVac, Hayat-Vax, and BioNTech/Pfizer) available for Kazakhstan’s population (p 0.27).